Kedaara Invests $200M in Tynor to Expand Ortho Platform
Private equity firm Kedaara Capital has acquired a majority stake of approximately 51% in Tynor Orthotics for 200 million dollars. Consequently, this landmark transaction marks a substantial expansion of Kedaara's healthcare and medical devices portfolio in India. Tynor Orthotics has long served healthcare professionals as a prominent manufacturer of orthopaedic supports, mobility aids, and rehabilitation solutions.
Strategic Investment in Tynor Orthotics
Under this agreement, Kedaara Capital will partner with promoters Dr. P.J. Singh and A.J. Singh alongside French orthopaedic leader Thuasne. Furthermore, Thuasne has maintained a strategic partnership with Tynor since 2010. Therefore, the collaboration will leverage combined technical expertise to accelerate growth across domestic and international markets. Additionally, O3 Capital served as the exclusive financial advisor for this major transaction.
Expanding Orthopaedic and Rehabilitation Solutions
Founded in 1993 in Mohali, the company operates three manufacturing facilities spanning 6.5 lakh square feet. In addition, these facilities utilize lean manufacturing systems to meet stringent global standards. Today, the brand distributes products across more than 300,000 retail outlets and 8,000 hospitals in 60 countries. Consequently, its clinical aids and wellness platforms have supported more than 100 million individuals globally.
Impact on the Indian Medical Devices Sector
India's medical devices sector remains among the fastest-growing healthcare segments globally. Therefore, this strategic investment reinforces institutional confidence in homegrown medical manufacturing. Dr. P.J. Singh emphasized that the alliance will strengthen supply chain networks for both developing and developed nations. As a result, orthopaedic specialists and clinicians can expect broader access to advanced rehabilitation technologies.
Frequently Asked Questions
Q1: What is the valuation and stake acquired in Tynor Orthotics?
Kedaara Capital invested approximately $200 million to secure a majority stake of about 51% in the company.
Q2: How will this partnership affect clinical product availability?
The investment will enhance manufacturing capabilities, thereby improving the distribution of orthopaedic supports and mobility aids across India and overseas.
Q3: Who are the existing key partners in Tynor Orthotics?
The company continues its partnership with promoters Dr. P.J. Singh and A.J. Singh, as well as French orthopaedic manufacturer Thuasne.
References
- - ETHealthworld. Kedaara Capital bets on India’s orthopaedic market with $200 million Tynor deal.
- Mint. Kedaara Capital invests $200 million in Tynor Orthotics.
- Business Standard. Kedaara Capital Announces a USD 200 million Strategic Investment in Tynor.
